Channels
Drug Development, News, Syndication, Xconomy »
SD Biotech Roundup: Elevation Pharmaceuticals, BioSurplus, and More |  |
|
Posted by sandiegobiotech May 17th, 2012 .
| |
| No Comments |
[[Click headline to continue reading.]]
Drug Development, News, Syndication, Xconomy »
San Diego’s MediciNova Nears Turning Point with Lead Drug for Asthma | |
|
Posted by sandiegobiotech May 8th, 2012 .
| |
| No Comments |
[[Click headline to continue reading.]]
Diagnostics, News, Syndication, Xconomy »
Hologic Buys Gen-Probe for $3.7B, Making Molecular Diagnostics Push | |
|
Posted by sandiegobiotech April 30th, 2012 .
| |
| No Comments |
[[Click headline to continue reading.]]
Drug Development, News, Syndication, Xconomy »
AstraZeneca Reloads its Pipeline with Ardea Deal, Could be Still Hunting | |
|
Posted by sandiegobiotech April 23rd, 2012 .
| |
| No Comments |
[[Click headline to continue reading.]]
Diagnostics, News, Syndication, Xconomy »
Illumina Stays Independent, Roche Walking Away | |
|
Posted by sandiegobiotech April 18th, 2012 .
| |
| No Comments |
[[Click headline to continue reading.]]
Diagnostics, News, Syndication, Xconomy »
AIDS Drugs Were the Start. Let’s See More FDA Accelerated Approvals | |
|
Posted by sandiegobiotech March 12th, 2012 .
| |
| No Comments |
[[Click headline to continue reading.]]
Diagnostics, Drug Development, Drug Discovery, Featured, SDBN Blog »
San Diego’s Biotechnology Companies: Who’s Taking Off? |  |
|
Posted by Lara March 8th, 2012 .
| |
| No Comments |
Image Courtesy Flickr User JoF
Updates to San Diego Biotechnology Company Directory
| Company | Status | Details |
|---|---|---|
| 1060 Discovery Engineering | Added | |
| Adnavance | Removed | |
| ALARIS Medical Systems | Removed | Now under Cardinal Health |
| Alere | Added | Acquired Biosite |
| Altair Therapeutics | Removed | Shut down |
| Amira Pharmaceuticals | Removed | Acquired by Bristol-Myers Squibb |
| Amplyx Pharmaceuticals | Added | |
| Aperio | Added | |
| Applied Proteomics | Added | |
| Aragon Pharmaceutical | Added | |
| Astute Medical | Added | BioSite spinoff |
| AvantGen | Added | |
| Avelas Biosciences | Added | |
| Azco Biotech, Inc. | Added | |
| Balboa Bio | Removed | |
| Bio Applied Technologies Joint, Inc. | Added | |
| BioAtla | Added | |
| Biocept | Added | |
| BioLaurus | Added | |
| BioMedica, Inc. | Removed | |
| BioSettia | Added | |
| BioSite | Removed | Acquired by Alere |
| Biotix | Added | |
| BPS Bioscience, Inc | Added | |
| Calmune Corporation | Removed | |
| Carolus Therapeutics | Added | |
| Cebix | Added | |
| Crinetics | Added | Started by ex-Neurocrine employees |
| CryoCor, Inc. | Removed | |
| Diverse Diagnostics | Removed | |
| Dx Innovations | Removed | |
| Elcelyx | Added | |
| Enigma diagnostics | Added | |
| Essentialis | Added | |
| Etaluma | Added | |
| EuMederis Pharmaceuticals, Inc. | Added | |
| Expedeon | Added | |
| Genetex | Added | |
| Genofi | Added | |
| GenTarget Inc, | Added | |
| GenVault | Added | Existing, missed in original directory |
| Harbor Biosciences | Added | Changed name from Hollis Eden |
| Helixis | Removed | Acquired by Illumina |
| HemaQuest | Added | |
| Hollis-Eden | Removed | Changed name to Harbor Biosciences |
| Iapyx Medical | Removed | |
| Icx Biosystems | Removed | |
| IDM Pharma, Inc. | Removed | Acquired by Takeda 2009 |
| Inception Sciences | Added | Amira spinoff |
| Inhibrx | Added | |
| KFx Medical, Inc. | Removed | |
| Kinagen, Inc. | Added | |
| Kinexis, Inc. | Removed | |
| Kyowa Hakko Kirin California, Inc. | Added | |
| LeGene Biosciences | Added | |
| LiquidGrids | Added | Previously known as Swarmology |
| MabPrex.com | Added | |
| MediVas LLC | Removed | |
| Metabasis Therapeutics, Inc. | Removed | |
| MO BIO Laboratories | Added | Existing company missed in original directory |
| Molecular Response | Added | |
| Mpex Pharmaceuticals | Removed | Name change to Rempex |
| Nacalai usa | Added | |
| NeoMPS, Inc. | Removed | Now part of PolyPeptide Group |
| NeuroGenetic Pharmaceuticals Inc. | Added | |
| Novalar | Removed | |
| Nventa | Removed | Merger with Akela Pharma, Inc March 27, 2008 |
| Oceanside Pharmacuticals | Added | |
| Orbigen | Removed | |
| ORQIS Medical Corporation | Removed | |
| PAGEgel, Inc. | Removed | Merged with Expedeon/Protein Discovery |
| Paramount BioSciences, LLC | Removed | |
| Pegasus Cleanroom Services | Added | |
| Perry Scientific | Removed | Acquired by Absorption Systems |
| Pfenex | Added | |
| PharmaCircle | Added | |
| Phenometrics | Added | |
| Phenomix | Removed | |
| PliCare Therapeutics | Added | |
| ProteinLabs | Added | |
| Rebexsess | Added | |
| Rempex Pharmaceuticals | Added | Name change from Mpex |
| Renascions | Added | |
| SeaSpine | Added | |
| Serametrix | Added | |
| SG Biofuels | Added | |
| SGX Pharmaceuticals, Inc. | Removed | As of 2008, acting as subsidiary of Lilly |
| Sidney Kimmel Cancer Center | Removed | |
| Sonexa Therapeutics | Added | |
| SorrentoTherapeutics.com | Added | |
| Sova Pharmaceuticals | Added | |
| Strategic Enzyme Applications | Added | |
| Tanox | Removed | |
| TargeGen, Inc. | Removed | Acquired by Sanofi-Aventis |
| Targeson Inc | Added | |
| Theragence Inc. | Added | |
| TheraKem | Removed | |
| Torrey Path, LLC | Removed | |
| TorreyPines Therapeutics | Removed | |
| TrovaGene | Added | |
| Tulip BioMed, Inc. | Removed | |
| Ultimate Labs | Added | |
| Vasgene | Removed | |
| Verus Pharmaceuticals, Inc | Removed | |
| ViaCyte Technologies: Stem Cell Engineering | Added | |
| VivaMab, LLC | Added | |
| West Wireless Health Institute | Added | |
| Zacharon Pharmaceuticals | Added |
A recent report suggests evidence that the San Diego biotech scene is going strong. Released in December 2011 the Life Sciences Cluster Report by Jones Lang LaSalle rates San Diego #7 in the global biotech clusters. The report examines global locations for viable industry hubs, and defines a “cluster” by a multiple data points including:
- Educated workforce
- Venture and investment capital
- Centers of excellence and innovation
- Industry-friendly political structures
- Institutions of higher learning
- Target economic development incentives
- Patent protection
- Other associations and supporting infrastructure
Ranking in the top 10 for funding – third in VC and sixth for NIH funding – it seems that the money is rolling in for San Diego. The 97-page study says San Diego’s dense concentration of incubator and start-ups is expected to continue growth in the near future.
Each of the submarkets reviewed – UTC, Torrey Pines, Sorrento Mesa, and Sorrento Valley – experienced growth in 2011, aside from Sorrento Mesa being almost completely leased. The report forecasts continued recovery in rents, vacancies tightening and, due to a lack of new development, re-positioning of older properties to meet demands for higher quality facilities, particularly in Sorrento Mesa.
Additionally, Torrey Pines, San Diego’s largest submarket, has seen a resurgence of growth, with more life science companies acquiring larger spaces. The report states that in 2011 Verenium signed a deal larger than Torrey Pines has seen in two years.
NIH grants have increased 28 percent from 2010 and by 70 percent from 2008. The outlook is sunny for San Diego in 2012, with a continued increase expected in the number of start-ups and dispersal of capital from venture capital and government funds.
A PDF of the complete report can be downloaded here.
Thanks to Flickr user JoF for this image of gliders taking off and landing at Torrey Pines, where many San Diego life science companies also ‘take off.’
More...Diagnostics, News, Syndication, Xconomy »
San Diego Life Sciences Roundup: Aragon, Illumina, CareFusion, & More | |
|
Posted by sandiegobiotech March 8th, 2012 .
| |
| No Comments |
[[Click headline to continue reading.]]
Drug Development, Drug Discovery, Headline, SDBN Blog, SDBN Events »
SDBN March 26th 2012 Event with Organovo |  |
|
Posted by Mary Canady March 6th, 2012 .
| |
| No Comments |
Organovo is an exciting San Diego biotech company with technology to create human tissue through a technique called 3D bioprinting. The tissue can be used for drug discovery and development, and the company has been included in the MIT Technology Review’s 2012 TR50 list of the world’s most innovative companies. The excitement around Organovo has grown since they recently announced funding and their stock is now publicly traded. You’ll get the chance to hear from CEO Keith Murphy at our March 26th event, he’ll give a presentation titled ‘3D Bioprinting – Delivering Tissue on Demand for Drug Discovery & Development.’
At this event, we will delve into innovation and how it happens. What does it take to make an outstanding product – a game changer? We all have ideas but how does an idea get to be a reality? What are the barriers to innovation? It’s not just time, money and people. It’s even how you think about the problem.
We have two companies that are innovating to success:
Organovo, the featured company, will discuss how they overcame barriers to achieve an industry changing technology that still seems futuristic and impossible – printing tissue.
Invetech, the event sponsor, helps people translate their ideas into products. They will share a few key learnings of how to approach innovation.
We want to hear from the local innovators at this event,
- Do you have an idea but are stuck?
- How have you been successful in innovation?
- What barriers are in your way?
We’re having a contest to see who has the best idea for improving innovation in San Diego. During registration, or on LinkedIn or Twitter (tag with #Invetech), complete this statement: “My innovation idea is ______.” It can be a product idea or a general idea to improve the innovation culture in San Diego. We’ll discuss and vote on the best idea for innovation at the event and the winner will get two free passes to an SDBN event and a $15 gift card to Green Flash Brewery.
Sponsors
Premier
 |
Invetech is a contract product development and manufacturing consultancy working with companies worldwide. We provide a range of instrument, medical device and consumables development and manufacturing services that develop break-through products and solve complex automation challenges. With over 200 in-house specialists and experience drawn from over 5,000 projects, we work with medical device, clinical diagnostics, life sciences and drug discovery companies. Operating from locations in North America, Europe and Asia Pacific, our clients range from start-ups through to multinationals. Our proven design, engineering and manufacturing processes deliver shorter time-to-market, reduced risk, and enhanced product quality.
If you’re interested in sponsoring this event, please contact us.
Event Details
Who: Biotechnology professionals in the greater San Diego area
What: SDBN March 26th Event with Organovo
When: Monday, March 26th 2012, 5:30-8:30 p.m.
Where: Green Flash Tasting Room, 6550 Mira Mesa Boulevard, San Diego, CA 92121 (Directions below)
Cost: $25/20 (Academic), dinner provided, beverages for purchase (30 Green Flash beers on tap, soda), complimentary water.
Contact: http://sdbn.org/contact
For more information about the event: http://sdbn.org/marchevent
Directions: From the west: From the 805 North or South exit Mira Mesa Blvd, head east for 2.0 miles, the Green Flash Tasting Room will be on the left/north side of the street at Flanders Drive. From the east: From the 15 North or South exit Mira Mesa Blvd, head west for 3.6 miles, the Green Flash Tasting Room will be on the right/north side of the street at Flanders Drive.
Parking: The Green Flash lot holds about 70 cars, so come early and carpool if you’d like to park there. You can also park on the street, but be very mindful that there are some poorly marked ‘no parking’ areas, especially on Sequence where there is a center lane.
Drug Development, News, Syndication, Xconomy »
San Diego’s Aragon Raises $42 Million, Targets Hormone-Driven Cancers | |
|
Posted by sandiegobiotech March 5th, 2012 .
| |
| No Comments |
[[Click headline to continue reading.]]
